Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Insulin Sensitivity in Insulin Resistant Human Adipocytes

Abstract

Insulin resistance is an essential characteristic of type 2 diabetes mellitus (T2DM), which can be induced by glucotoxicity and adipose chronic inflammation. Mesenchymal stem cells (MSCs) and their exosomes were reported to ameliorate T2DM and its complications by their immunoregulatory and healing abilities. Exosomes derived from MSCs contain abundant molecules to mediate crosstalk between cells and mimic biological function of MSCs. But the role of exosomes derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) in insulin resistance of human adipocytes is unclear. In this study, exosomes were harvested from the conditioned medium of hUC-MSCs and added to insulin-resistant adipocytes. Insulin-stimulated glucose uptake was measured by glucose oxidase/peroxidase assay. The signal pathway involved in exosome-treated adipocytes was detected by RT-PCR and Western blotting. The biological characteristics and function were compared between hUC-MSCs and human adipose-derived mesenchymal stem cells (hAMSCs). The results showed that hAMSCs had better adipogenic ability than hUC-MSCs. After induction of mature adipocytes by adipogenesis of hAMSC, the model of insulin-resistant adipocytes was successfully established by TNF-α and high glucose intervention. After exosome treatment, the insulin-stimulated glucose uptake was significantly increased. In addition, the effect of exosomes could be stabilized for at least 48 h. Furthermore, the level of leptin was significantly decreased, and the mRNA expression of sirtuin-1 and insulin receptor substrate-1 was significantly upregulated after exosome treatment. In conclusion, exosomes significantly improve insulin sensitivity in insulin-resistant human adipocytes, and the mechanism involves the regulation of adipokines.

Keywords

type 2 diabetes mellitus / insulin resistance / hyperglycemia injury / mesenchymal stem cells / exosome

References

[1] ReuschJE, MansonJE. Management of Type 2 Diabetes in 2017: Getting to Goal. JAMA, 2017, 317(10): 1015-1016

[2] ZhangY, MeiHL, ChangXA, et al.. Adipocyte-derived microvesicles from obese mice induce M1 macrophage phenotype through secreted miR-155. J Mol Cell Biol, 2016, 8(6): 505-517

[3] RonningenT, ShahA, ReinerA, et al.. Epigenetic priming of inflammatory response genes by high glucose in adipose progenitor cells. Biochem Biophys Res Commun, 2015, 467(4): 979-986

[4] LoKA, KennedyN, HanM, et al.. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Reports, 2013, 5(1): 259-270

[5] KupsalK, MudigondaS, GundapaneniK, et al.. Glucotoxicity and lipotoxicity induced beta-cell apoptosis in type 2 diabetes mellitus. Int J Anal Bio-sci, 2015, 3(4): 84-89

[6] AnX, LiL, ChenY, et al.. Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6. Int J Mol Sci, 2016, 17(4): 483

[7] RebelattoC, AguiarA, MoretãoM, et al.. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood), 2008, 233(7): 901-913

[8] XieZY, HaoHJ, TongC, et al.. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells, 2016, 34(3): 627-639

[9] XieM, HaoHJ, ChengY, et al.. Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats. Biochem Biophys Res Commun, 2017, 483(1): 435-441

[10] PhinneyD, PittengerM. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells, 2017, 35(4): 851-858

[11] LawsonC, VicencioJ, YellonD, et al.. Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J Endocrinol, 2016, 228(2): R57-R71

[12] SabryD, MarzoukS, ZakariaR, et al.. The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats. Biotechnol Lett, 2020, 42(8): 1597-1610

[13] ZhuLL, HuangX, YuW, et al.. Transplantation of adipose tissue-derived stem cell-derived exosomes ameliorates erectile function in diabetic rats. Andrologia, 2018, 50(2): e12871

[14] WangJ, MiY, WuS, et al.. Exosomes from adipose-derived stem cells protect against high glucose-induced erectile dysfunction by delivery of corin in a streptozotocin-induced diabetic rat model. Regenerative therapy, 2020, 14: 227-233

[15] ZhaoH, ShangQ, PanZ, et al.. Exosomes from Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity through Polarizing M2 Macrophages and Beiging in White Adipose Tissues. Diabetes, 2018, 67: 235-247

[16] MoreiraA, KahlenbergS, HornsbyP, et al.. Therapeutic potential of mesenchymal stem cells for diabetes. J Mol Endocrinol, 2017, 59(3): R109-R120

[17] PanXH, HuangX, RuanGP, et al.. Umbilical cord mesenchymal stem cells are able to undergo differentiation into functional islet-like cells in type 2 diabetic tree shrews. Mol Cell Probes, 2017, 34: 1-12

[18] KobolakJ, DinnyesA, MemicA, et al.. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods, 2016, 99: 62-68

[19] VishwanathD, SrinivasanH, PatilMS, et al.. Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog. J Cell Commun Signal, 2013, 7(2): 129-140

[20] XiaoY, ZhengL, ZouX, et al.. Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy. J Extracell Vesicles, 2019, 8(1): 1625677

[21] NorenH, EvansM. Extracellular vesicles as signaling mediators in type 2 diabetes mellitus. Am J Physiol Cell Physiol, 2020, 318(6): C1189-C1199

[22] YingW, RiopelM, BandyopadhyayG, et al.. Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity. Cell, 2017, 171(2): 372-384

[23] KitaS, MaedaN, ShimomuraI. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Invest, 2019, 129(10): 4041-4049

[24] ObataY, KitaS, KoyamaY, et al.. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. JCI Insight, 2018, 3(8): e99680

[25] KönnerA, BrüningJ. Selective insulin and leptin resistance in metabolic disorders. Cell Metab, 2012, 16(2): 144-152

[26] LiangF, KumeS, KoyaD. SIRT1 and insulin resistance. Nat Revi Endocrinol, 2016, 5(7): 178-183

[27] YuanY, ShiM, LiL, et al.. Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1 alpha pathway. Clin Sci (Lond), 2016, 130(23): 2181-2198